Category: Approval/Launch Region: Asia · India Company: Alkem Laboratories Ltd

Alkem Laboratories Launches Ibuprofen Famotidine Tablets In US Market

Alkem Laboratories Launches Ibuprofen Famotidine Tablets In US Market
Drug firm Alkem Laboratories on Wednesday announced the launch of Ibuprofen and Famotidine tablets, used to relieve the symptoms of rheumatoid arthritis and osteoarthritis, in the US.Ibuprofen and Famotidine tablets are a generic therapeutic equivalent version of Horizon Medicines LLC's Duexis tablets.Alkem Laboratories has launched Ibuprofen and Famotidine tablets in the strength of 800 mg/26.6 mg in the United States, following an approval from the United States Food and Drug Administration (USFDA), the company said in a regulatory filing.

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!